JP2009536967A5 - - Google Patents

Download PDF

Info

Publication number
JP2009536967A5
JP2009536967A5 JP2009511159A JP2009511159A JP2009536967A5 JP 2009536967 A5 JP2009536967 A5 JP 2009536967A5 JP 2009511159 A JP2009511159 A JP 2009511159A JP 2009511159 A JP2009511159 A JP 2009511159A JP 2009536967 A5 JP2009536967 A5 JP 2009536967A5
Authority
JP
Japan
Prior art keywords
compound according
carbon atoms
alkyl
substituted
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009511159A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009536967A (ja
Filing date
Publication date
Priority claimed from US11/745,317 external-priority patent/US7557095B2/en
Application filed filed Critical
Publication of JP2009536967A publication Critical patent/JP2009536967A/ja
Publication of JP2009536967A5 publication Critical patent/JP2009536967A5/ja
Pending legal-status Critical Current

Links

JP2009511159A 2006-05-12 2007-05-09 高眼圧症状治療に有用なイソチアゾリジン類 Pending JP2009536967A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74711506P 2006-05-12 2006-05-12
US11/745,317 US7557095B2 (en) 2006-05-12 2007-05-07 Therapeutic compounds
PCT/US2007/068518 WO2007134085A2 (en) 2006-05-12 2007-05-09 Isothiazolidines useful in the treatment of ocular hypertensive conditions

Publications (2)

Publication Number Publication Date
JP2009536967A JP2009536967A (ja) 2009-10-22
JP2009536967A5 true JP2009536967A5 (OSRAM) 2010-06-24

Family

ID=38606676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009511159A Pending JP2009536967A (ja) 2006-05-12 2007-05-09 高眼圧症状治療に有用なイソチアゾリジン類

Country Status (7)

Country Link
US (2) US7557095B2 (OSRAM)
EP (1) EP2044041A2 (OSRAM)
JP (1) JP2009536967A (OSRAM)
AU (1) AU2007249443B2 (OSRAM)
BR (1) BRPI0711461A2 (OSRAM)
CA (1) CA2652866A1 (OSRAM)
WO (1) WO2007134085A2 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7557095B2 (en) * 2006-05-12 2009-07-07 Allergan, Inc. Therapeutic compounds
US7960379B2 (en) * 2008-03-14 2011-06-14 Allergan, Inc. Therapeutic compounds
US8314250B2 (en) * 2009-11-24 2012-11-20 Hoffmann-La Roche Inc. Sultam derivatives
US8999889B2 (en) 2010-02-01 2015-04-07 Basf Se Substituted ketonic isoxazoline compounds and derivatives for combating animal pests
AR083646A1 (es) 2010-10-01 2013-03-13 Basf Se Compuestos de imina, composiciones veterinarias y agricolas que los contienen y su uso en el control de plagas de invertebrados
WO2012042006A1 (en) 2010-10-01 2012-04-05 Basf Se Imine compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462968A (en) * 1994-01-19 1995-10-31 Allergan, Inc. EP2 -receptor agonists as agents for lowering intraocular pressure
US5519040A (en) 1994-04-29 1996-05-21 Allergan Substituted thiazole sulfonamides as antiglaucoma agents
US5902726A (en) 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
TW401408B (en) 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6465501B2 (en) 2000-07-17 2002-10-15 Wyeth Azolidines as β3 adrenergic receptor agonists
US6927216B2 (en) * 2000-10-03 2005-08-09 Bristol-Myers Squibb Pharma Company Cyclic sulfonyl compounds as inhibitors of metalloproteases
US6476064B1 (en) 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
CA2463102C (en) * 2001-10-23 2011-05-10 Applied Research Systems Ars Holding N.V. Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
DE60235198D1 (de) * 2001-12-20 2010-03-11 Merck Serono Sa Coinsins Pyrrolidin-derivatie als prostaglandin-modulatoren
WO2003074483A1 (en) * 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
JP2005104836A (ja) * 2003-08-08 2005-04-21 Ono Pharmaceut Co Ltd プロスタグランジン誘導体
US7557095B2 (en) * 2006-05-12 2009-07-07 Allergan, Inc. Therapeutic compounds
US7960379B2 (en) * 2008-03-14 2011-06-14 Allergan, Inc. Therapeutic compounds

Similar Documents

Publication Publication Date Title
JP2009543792A5 (OSRAM)
JP2009541340A5 (OSRAM)
JP2010500416A5 (OSRAM)
JP2009535426A5 (OSRAM)
JP2009543795A5 (OSRAM)
JP2010500976A5 (OSRAM)
JP5024039B2 (ja) インドール化合物およびその用途
WO2008008660B1 (en) Cyclopentane derivatives as antiglaucoma agents
JP2009536967A5 (OSRAM)
JP2009543794A5 (OSRAM)
JP2010077141A5 (OSRAM)
JP2010536761A5 (OSRAM)
CA2825172A1 (en) Indole derivative and pharmacologically acceptable salt of same
JP2010530897A5 (OSRAM)
JP2010090149A5 (OSRAM)
JP2010510232A5 (OSRAM)
WO2008008718B1 (en) Cyclopentane derivatives as antiglaucoma agents
JP2011500818A5 (OSRAM)
JP2012502048A5 (OSRAM)
WO2008008701B1 (en) Substituted cyclopentane derivatives as therapeutic agents
WO2011013624A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
JP2008518013A5 (OSRAM)
JP2009538328A5 (OSRAM)
JPWO2006043655A1 (ja) 吸入用医薬組成物
JP2008520737A5 (OSRAM)